These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 23323860)
21. Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes. Lu G; Rausell-Palamos F; Zhang J; Zheng Z; Zhang T; Valle S; Rosselot C; Berrouet C; Conde P; Spindler MP; Graham JG; Homann D; Garcia-Ocaña A Diabetes; 2020 Aug; 69(8):1692-1707. PubMed ID: 32381645 [TBL] [Abstract][Full Text] [Related]
22. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes. Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268 [TBL] [Abstract][Full Text] [Related]
23. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
24. Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes. Thomas HE; Graham KL; Chee J; Thomas R; Kay TW; Krishnamurthy B Ann N Y Acad Sci; 2013 Apr; 1283():81-6. PubMed ID: 23167495 [TBL] [Abstract][Full Text] [Related]
25. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Rabinovitch A Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667 [TBL] [Abstract][Full Text] [Related]
26. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426 [TBL] [Abstract][Full Text] [Related]
27. Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells. Dettmer R; Niwolik I; Cirksena K; Yoshimoto T; Tang Y; Mehmeti I; Gurgul-Convey E; Naujok O Diabetologia; 2022 May; 65(5):829-843. PubMed ID: 35122482 [TBL] [Abstract][Full Text] [Related]
28. Thymic B Cell-Mediated Attack of Thymic Stroma Precedes Type 1 Diabetes Development. Pinto AI; Smith J; Kissack MR; Hogg KG; Green EA Front Immunol; 2018; 9():1281. PubMed ID: 29930554 [TBL] [Abstract][Full Text] [Related]
30. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes. Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568 [TBL] [Abstract][Full Text] [Related]
31. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483 [TBL] [Abstract][Full Text] [Related]
32. Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes. Stefan-Lifshitz M; Karakose E; Cui L; Ettela A; Yi Z; Zhang W; Tomer Y JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721151 [TBL] [Abstract][Full Text] [Related]
33. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Rabinovitch A; Suarez-Pinzon WL Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467 [TBL] [Abstract][Full Text] [Related]
34. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375 [TBL] [Abstract][Full Text] [Related]
35. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090 [TBL] [Abstract][Full Text] [Related]
36. Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat. Jörns A; Arndt T; Yamada S; Ishikawa D; Yoshimoto T; Terbish T; Wedekind D; van der Meide PH; Lenzen S J Mol Med (Berl); 2020 Aug; 98(8):1125-1137. PubMed ID: 32607871 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction. Mathews CE; Suarez-Pinzon WL; Baust JJ; Strynadka K; Leiter EH; Rabinovitch A J Immunol; 2005 Jul; 175(2):1248-56. PubMed ID: 16002729 [TBL] [Abstract][Full Text] [Related]
38. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice. Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715 [TBL] [Abstract][Full Text] [Related]
39. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970 [TBL] [Abstract][Full Text] [Related]
40. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]